202 related articles for article (PubMed ID: 18603524)
1. Physician-industry interactions: there is no such thing as a free lunch.
Tsai HJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
[No Abstract] [Full Text] [Related]
2. A national survey of physician-industry relationships.
Sade RM
N Engl J Med; 2007 Aug; 357(5):507; author reply 508. PubMed ID: 17671263
[No Abstract] [Full Text] [Related]
3. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
4. Doctors and drug companies: the beauty and the beast?
Guömundsson S
Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
[No Abstract] [Full Text] [Related]
5. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
Blehart B
J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
[No Abstract] [Full Text] [Related]
6. [Ethics and Transparency Committee on the Relationship Physician-Industry (CETREMI); suggestions to doctors in their relations with pharmaceutical industry].
Lifshitz A; Halabe J; Jasso L; Frati A; Alva C; Arrieta Ó; Burgos R; Campillo C; Celis MÁ; de la Llata M; Domínguez J; Islas R; Moreno M; Plancarte R; Reyes A; Soda A; Verástegui E; Sotelo J
Gac Med Mex; 2016; 152(3):295-6. PubMed ID: 27335182
[No Abstract] [Full Text] [Related]
7. The ethics of the medical-pharmaceutical relationship.
Vashi NA; Latkowski JA
Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
[TBL] [Abstract][Full Text] [Related]
8. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
Quan SF
J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
[No Abstract] [Full Text] [Related]
9. No more free lunches: how to dance with porcupines.
Rudolphy S
BMJ; 2003 Aug; 327(7410):341. PubMed ID: 12907495
[No Abstract] [Full Text] [Related]
10. A national survey on the effect of pharmaceutical promotion on medical students.
Vainiomäki M; Helve O; Vuorenkoski L
Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854
[TBL] [Abstract][Full Text] [Related]
11. No more free lunches: it is time to own up.
Fitzpatrick C
BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907499
[No Abstract] [Full Text] [Related]
12. Conflict of interest in the physician interface with the biomedical industry.
Minnigan H; Chisholm CD
Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
[TBL] [Abstract][Full Text] [Related]
13. The dos and don'ts of collaborating with industry.
Moynihan R
BMJ; 2012 May; 344():e3247. PubMed ID: 22569871
[No Abstract] [Full Text] [Related]
14. No more free lunches: it is time we all grew up.
Wessely S
BMJ; 2003 Aug; 327(7410):341. PubMed ID: 12907497
[No Abstract] [Full Text] [Related]
15. Prevention--early detection--treatment? All of the above, please!
Jacobsen G
Med Teach; 2004 Nov; 26(7):591-3. PubMed ID: 15763846
[TBL] [Abstract][Full Text] [Related]
16. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
Brett AS; Burr W; Moloo J
Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
[TBL] [Abstract][Full Text] [Related]
17. Medical students protest perks from drug companies.
Opar A
Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
[No Abstract] [Full Text] [Related]
18. Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations.
Rosenbaum L
N Engl J Med; 2015 May; 372(19):1860-4. PubMed ID: 25946288
[No Abstract] [Full Text] [Related]
19. Relationships between medical students and drug companies in New Zealand.
Wyber R; Fancourt N; Stone B
N Z Med J; 2011 Aug; 124(1341):58-64. PubMed ID: 21959637
[TBL] [Abstract][Full Text] [Related]
20. Student rally. Med school attendees write ethics code on drug firms.
Romano M
Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
